State of Wisconsin Investment Board’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,000
Closed -$29.9K 2474
2023
Q3
$29.9K Sell
23,000
-40,900
-64% -$66.1K ﹤0.01% 2456
2023
Q2
$110K Sell
63,900
-39,100
-38% -$62.1K ﹤0.01% 2217
2023
Q1
$150K Sell
103,000
-42,900
-29% -$82.2K ﹤0.01% 2325
2022
Q4
$236K Sell
145,900
-22,344
-13% -$51.4K ﹤0.01% 2187
2022
Q3
$564K Buy
168,244
+44
+0% +$199 ﹤0.01% 1915
2022
Q2
$612K Buy
168,200
+50,800
+43% +$230K ﹤0.01% 1967
2022
Q1
$849K Buy
117,400
+67,200
+134% +$573K ﹤0.01% 1674
2021
Q4
$682K Hold
50,200
﹤0.01% 1573
2021
Q3
$1.05M Buy
50,200
+1,194
+2% +$25.6K ﹤0.01% 1435
2021
Q2
$1.17M Buy
+49,006
New +$1.24M ﹤0.01% 1405

Other funds holding KRON

State of Wisconsin Investment Board's KRON Position: Q4 2023 in Review

State of Wisconsin Investment Board sold out of Kronos Bio (KRON) in Q4 2023, closing a stake of 23,000 shares — an estimated $29.9K sold.

State of Wisconsin Investment Board first reported a position in KRON in Q2 2021 and held it in 10 quarters. The position peaked at $1.17M in Q2 2021. 60 funds tracked by Wall St. Rank hold KRON as of Q4 2023.

  • State of Wisconsin Investment Board reported no remaining Kronos Bio position as of Q4 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 23,000 Kronos Bio shares in Q4 2023, an estimated $29.9K.
  • State of Wisconsin Investment Board first reported a position in Kronos Bio in Q2 2021 and held it in 10 quarters.
  • State of Wisconsin Investment Board's Kronos Bio position peaked at $1.17M in Q2 2021.
  • 60 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2023, filed 12 Feb 2024.